Detalles de la búsqueda
1.
Characterization of mutations in hepatitis B virus DNA isolated from Japanese HBsAg-positive blood donors in 2021 and 2022.
Arch Virol
; 169(5): 103, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38632180
2.
Mycobacterium bovis BCG-mediated suppression of Th17 response in mouse experimental autoimmune encephalomyelitis.
Immunopharmacol Immunotoxicol
; 43(2): 203-211, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33541144
3.
Short duration of diabetes and disuse of sulfonylurea have any association with insulin cessation of the patients with type 2 diabetes in a clinical setting in Japan (JDDM 30).
Endocr J
; 60(3): 305-10, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23149657
4.
Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70).
J Diabetes Investig
; 14(1): 75-80, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36268571
5.
Self-reported rate of eating is significantly associated with body mass index in Japanese patients with type 2 diabetes. Japan Diabetes Clinical Data Management Study Group (JDDM26).
Appetite
; 59(2): 252-5, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22609333
6.
Differences in Dental Care Referral for Diabetic Patients Between General Practitioners and Diabetes Specialists in Japan, Analyzed from NSAID-Study 3.
Diabetes Ther
; 13(2): 379-385, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34958439
7.
Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61).
J Diabetes Investig
; 13(1): 65-73, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34191401
8.
Cross sectional study on proportion of sulfonylureas among various oral antidiabetic drugs using for Japanese patients with type 2 diabetes, analyzed from NSAID Study-2.
Diabetol Int
; 13(1): 169-176, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35059253
9.
Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15,652 patients.
Endocr J
; 57(6): 499-507, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20208396
10.
Nationwide Survey on Actual Interventions for Type 2 Diabetes by Japanese Practitioners (NSAID Study-1): Glycemic, Weight, and Blood Pressure Management.
Diabetes Ther
; 11(7): 1497-1511, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32440836
11.
Effect of canagliflozin on the overall clinical state including insulin resistance in Japanese patients with type 2 diabetes mellitus.
Diabetes Res Clin Pract
; 149: 140-146, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30716347
12.
Association between body mass index and core components of metabolic syndrome in 1486 patients with type 1 diabetes mellitus in Japan (JDDM 13).
Endocr J
; 55(6): 1025-32, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18753706
13.
[Two cases of C1INH deficiency with paroxysmal abdominal pain].
Nihon Shokakibyo Gakkai Zasshi
; 104(6): 799-803, 2007 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-17548946
14.
Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38).
J Diabetes Investig
; 7(3): 386-95, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27330726
15.
Surgical excision of neovascularization in retinal angiomatous proliferation.
Graefes Arch Clin Exp Ophthalmol
; 243(6): 519-24, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15965671
16.
Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats.
Psychopharmacology (Berl)
; 176(1): 30-8, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15071721
17.
Effects of food restriction on peroxisome proliferator-activated receptor-gamma and glucocorticoid receptor signaling in adipose tissues of normal rats.
Metabolism
; 53(1): 28-36, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14681838
18.
Effect of chronic administration of a CRF(1) receptor antagonist, CRA1000, on locomotor activity and endocrine responses to stress.
Eur J Pharmacol
; 457(2-3): 201-6, 2002 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-12464367
19.
[Genetic disorders caused by gain or loss of function of the mineralocorticoid receptor].
Nihon Rinsho
; 60(2): 361-6, 2002 Feb.
Artículo
en Japonés
| MEDLINE | ID: mdl-11857927
20.
Both glimepiride and high-dose metformin are important for sustained glucose lowering in Japanese type 2 diabetes patients on glimepiride-sitagliptin-metformin therapy: subanalysis of a single-center, open-label, randomized study.
Diabetes Technol Ther
; 16(7): 442-6, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24528246